Introduction
The human collectin, mannose-binding lectin (MBL), is an important protein of the humoral innate immune system. With multiple carbohydrate-recognition domains, it is able to bind to sugar groups displayed on the surfaces of a wide range of microorganisms. It is recognized to have a role in processes as diverse as complement activation, promotion of complement-independent opsonophagocytosis, modulation of inflammation, recognition of altered self-structures and apoptotic cell clearance (1).
The basic structural unit of MBL is a homotrimer of MBL peptides (sub-units) that self-associate into a collagen-like triple helix. Each peptide possesses a C-terminal calciumdependent lectin domain (CRD), which recognizes repetitive oligosaccharide moieties present on a wide array of pathogens; a short α-helical, hydrophobic neck region; a collagenous region and a cysteine-rich N-terminal region. Functional MBL circulates as higher order multimers (tetramers, pentamers and hexamers) of the structural (homotrimeric) unit. The higher order structure allows high-affinity interaction between MBL lectin domains and microbial oligosaccharides, resulting in conformational change of the MBL multimer and activation of associated molecules, the mannose-associated serine proteases (MASP) (2). There are two human MBL genes, but MBL-1 is a pseudogene and only MBL-2 encodes a protein product. The functional MBL-2 gene is located on chromosome 10 (q11.2-q21) and comprises four exons. Exon 1 encodes the signal peptide, a cysteine-rich region and part of the glycinerich collagenous region. Exon 2 encodes the remainder of the collagenous region and exon 3 encodes a α-helical coiledcoil structure, which is known as the "neck" region. Exon 4 encodes the CRD, which assumes a globular configuration. The promoter region of the MBL gene contains a number of regulatory elements that affect transcription of the protein (1-3).
In 1991, the complete nucleotide sequence of all four exons of the human MBL-2 gene was determined and a point mutation was observed in codon 54, substituting aspartic acid for glycine (4); in 1992, a second exon 1 mutation was identified in codon 57, resulting from the exchange of glycine by glutamic acid (5); and in 1994, a mutation was reported in codon 52, substituting arginine by cysteine (6). These point mutations are usually referred to as variants B, C and D respectively and are designated as allele 0, whereas the allele A indicating the wild type (3).
A common opsonic defect was found to be associated with low levels of the mannose-binding protein (7). Subsequently, low levels of this protein were associated with recurrent infections in childhood (8) . A variety of medical conditions have been related with MBL deficiency, such as acquired immunodeficiency syndrome (9), heart disease (3) and diabetes mellitus (10).
Diabetes mellitus is a metabolic disorder characterized by increased levels of glucose in the bloodstream because of defective secretion or activity of the hormone insulin (11). Type 1 diabetes results from cellular mediated autoimmune destruction of pancreatic b-cells, usually leading to total loss of insulin secretion (12). Type 2 diabetes results from insulin resistance and does not seem to have an auto-immune causation, because no destruction of cells of pancreatic islets is seen microscopically (13).
Diabetes mellitus is recognized as one of the main public health problems in Latin America affecting nearly 19 million people in the region. In Brazil it is estimated that the prevalence of this disease is 7.6% of the population older than 40 years (14). Peripheral vascular failure in diabetic patients impairs healing and produces physiological changes that decrease the capacity of the immune system, thereby increasing susceptibility to infections (15).
Periodontal disease is the most common dental manifestation in the oral cavity of diabetic patients (16) and has been reported to be the sixth classic complication of the diabetic patient (17). It is generally accepted that the presence of bacteria is a necessary but not sufficient condition for the development of periodontitis (18).
The relationship between the periodontopathogenic potential of the plaque and the immune response of the host determines the development of periodontal disease (19) . As the immune system plays an important role in the pathogenesis of the periodontal disease (20), it is conceivable that changes in serum levels of MBL due to genetic polymorphisms may be part of the susceptibility to periodontitis.
Interestingly, the periodontal pathogens Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis also appear to have mannan-rich polysaccharides on the cell surfaces, which can be a potential target for MBL binding (21) . For this reason the MBL can play an important role in host defense against periodontal pathogens.
This study investigated the association of periodontal disease with genetic polymorphism of the exon-1 (codons -52, -54, -57) of MBL2 gene using the technique of real-time PCR in a sample of Brazilian patients with type 2 diabetes mellitus.
Materials and Methods
The research project received approval from the Ethics in Research Committee of the Federal University of Pernambuco (protocol number 285/07). This study was carried out at two endocrinology services of the public healthcare system in Recife, Brazil (Hospital das Clínicas and Centro Médico Senador Ermírio de Moraes). A total of 100 patients with prior diagnosis of type 2 diabetes were evaluated between April 1 st and July 30 th , 2008. The sample was randomly obtained in accordance with the demand at the clinics involved.
All patients who presented for consultation during this period were approached and selected using the following inclusion and exclusion criteria.
Inclusion criteria: 1 -Diagnosis of type 2 diabetes; 2 -Having at least eight natural teeth; 3 -Agreeing to participate in the study. Araújo et al. Exclusion criteria: 1 -Using antibiotics for at least 6 months; 2 -Major medical complications (e.g. heart disease); 3 -Periodontal treatment in the previous 6 months; 4 -Being pregnant or breastfeeding. After free and informed written consent had been obtained, a clinical examination was performed in a dental chair by two previously calibrated researchers using a millimeter North Carolina-type (Trinity ® -São Paulo, SP, Brazil) periodontal probe. Six sites per tooth were evaluated (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual and mesiolingual), except for third molars. PD, BOP, CAL, PI and number of teeth present were recorded.
Periodontal disease was defined as four or more sites with a loss of attachment of 5 mm or more with one or more of those sites having a pocket of 4 mm or more (22). The loss of attachment corresponds to the distance from the most apical portion of the periodontal pocket to the cementoenamel junction. Thus the sample was divided into a control group (diabetic patients without periodontitis) and a study group (diabetic patients with periodontitis).
DNA isolation
After clinical examination, the collection of the scaling cells from the oral mucosa was carried out with appropriate cytobrush-type brushes (Kolplast ® -São Paulo, SP, Brazil), which were subsequently stored in 1 ml of saline solution of 0.9% chloride sodium (Laboratory Tayuyna Ltda -Nova Odessa, SP, Brazil). The collected material was stored at -20°C for extraction of the DNA.
The kit for extraction and purification of DNA, Geneclean ® , (GENECLEAN ® Kit, BIO 101, La Jolla, CA, USA) was used to extract the genetic material according to manufacturer's protocol.
MBL2 genotyping
The detection of polymorphism in the MBL2 gene was conducted by the technique of real time PCR (RT-PCR) using the melting temperature curve analysis (23).
MBL2 SNP genotyping was performed using the following primers designed with the Primer Express 1.5 software (Applied Biosystems, Foster City, CA, USA): forward primer 5'-AGGCATCAACGGCTT CCCA-3' and reverse primer 5'-CAGAA CAGCCCAACACGTACCT-3'. The expected amplicon length is 90 bp and its theoretical melting temperature is 84ºC. Amplification reactions were performed in a final volume of 25 μL with 1X SYBR Green I Amplification Master Mix (Euroclone, Milan, Italy), 150 picomoles of the forward primer, 50 picomoles of the reverse primer and 10 ng of genomic DNA. The cycling conditions were as follows: 95ºC for 10 min followed by 95ºC for 30 s and 60ºC for 1 min, repeated 40 times in the Rotor Gene-3000 apparatus (Corbett Research Mortlake, Sydney, Australia). At the end of the PCR, the dissociation protocol included a slow heating from 60º to 95ºC in 0.2ºC steps, with an 8-s interval between steps. Melting curve profiles were obtained using the dissociation software of the Rotor Gene-3000 apparatus (9).
The melting temperature assay allowed us to easily distinguish the melting profiles of the three MBL2 genotypes, which were AA, A0, and 00, respectively. The melting temperatures of the three MBL2 genotypes were as follows: A/A (one peak of 83.1 ± 0.1ºC), A/0 (two peaks of 82.6 ± 0.3 and 80.7 ± 0.1ºC), and 0/0 (one peak of 81.7 ± 0.1ºC) (9).
The genotyping was performed by overlapping the patients' curves with the curves of three control samples: one wild, one mutant and one for a heterozygote. Whenever there was an overlap between the curve of the patient with a standard curve, it was possible to infer the genotype in question.
The MBL2 genotype frequencies were in agreement with the Hardy-Weinberg equilibrium. Allele frequencies were calculated by direct gene counting and the differences analyzed by Fisher's exact test.
The confidence interval considered was 95%, so p-values less than 0.05 were accepted. The results that did not attain this value were considered to be without significance. All data analyses were performed using the statistical package SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
Results
The mean age of the patients during the data collection was 54.1 years (SD=9,54), 37/100 (37.0%) being male and 63/100 (63.0%) female. Table 1 presents the measurements of descriptive analysis that characterize the sample studied. The prevalence of periodontal disease in the sample studied is reported in Table 2 . Sixty and one per cent of the patients had periodontitis and 39% were healthy individuals. Regarding the distribution of genotypes, the sample presented 46.0% with the AA genotype, 54.0% the A0 and 0.0% the 00 genotype.
The association between MBL2 polymorphism and periodontal disease is reported in Table 3 : MBL2 polymorphisms genotype frequencies were in agreement with the Hardy-Weinberg equilibrium in both patients and controls. The frequencies of MBL2 polymorphisms reveal that 45.9% of the periodontitis patients were carrying the AA genotype and 54.1% the A0 genotype, while the healthy controls were carrying 46.2% and 53.8%, respectively. There were no significant differences between periodontitis patients and controls in the distribution of the genotypes MBL2 polymorphisms allele frequency is also shown in Table 3 . In the periodontitis group, 72.9% were carrying the A allele and 27.1% the 0 allele versus 73.0% and 27.0%, respectively, of the controls. The results indicated that there were no statistically significant differences in the frequency of the alleles of the MBL2 gene between the healthy and periodontitis individuals.
Discussion
It is well established that patients with diabetes exhibit a slight increase in the severity of periodontal disease when compared to non-diabetic (18). The present study showed a high frequency of periodontal disease in the diabetic population, 61% of the sample having periodontal disease. These results are in agreement with many studies that investigated the relationship between type 2 diabetes and periodontitis and observed the widespread existence of periodontal disease in this population (19, 22) .
Several biological mechanisms were proposed for a higher predisposition to periodontitis of diabetic subjects and include microangiopathy, neutrophil and leukocyte dysfunction, genetic predisposition, changes in collagen metabolism and in subgingival microbiota (17).
It is known that genetic heterogeneity can be a problem when we perform genetic screenings in Brazilian populations which characterized by an admixture of genotypes. It is not easy to determine the ethnic origin of Brazilian population, especially those of Northeastern Brazil who are known to derive from an admixture of African, Caucasian and Native American populations (estimated respectively, at 44%, 34%, and 22%) (24).
Although the genetic polymorphism of the MBL promotes the development of various diseases, it is still observed at high frequencies in populations. It has been suggested that the persistence of MBL gene polymorphisms at high frequencies may offer a potential advantage to the host. The low levels of functional MBL could reduce possible deleterious consequences owing to complement activation and subsequent release of inflammatory mediators that may lead to tissue damage (25).
In general, one-third of the white population is considered MBL deficient. Genetic studies are needed to link genetic polymorphism and susceptibility to the development of various diseases (26).
Homozygotes individuals for the mutant allele (0/0) produce MBL in undetectable quantities by enzymelinked immunosorbent assay (ELISA), while heterozygotes for the mutation (A/0) produce significantly reduced concentrations when compared with homozygotes individuals for the wild type allele (A/A) (5). In a recent review of the MBL2 gene, frequencies of the low-producing (A0) and deficient genotypes (00) of around 40% were reported for two Caucasian populations (Danish and British) (25). For one Brazilian population, the frequencies of these genotypes were 38.9% (9). In this study, in a type 2 diabetic population of northeast Brazil, the findings are similar to those of the previously reported frequencies, and the prevalence of genotypes encoding low MBL plasma levels (A0) was 54%.
Some studies related the association between MBL2 gene polymorphisms with diabetes mellitus. Patients with type 1 diabetes possessing the 0 allele have a higher risk for developing type 1 diabetes during childhood and adolescence (10). In patients with type 2 diabetes, measurements of MBL can provide prognostic information on mortality and the development of vascular complications (27).
In the current literature, few studies analyzed the correlation between the polymorphism of the MBL2 gene and the periodontal disease. Louropoulou et al. (28) investigated the correlation of polymorphisms in the MBL2 gene in relation to periodontitis in Caucasian population and observed that the prevalence of genotypes encoding for low and very low MBL plasma levels was higher for periodontitis patients than for healthy controls (44% and 35%, respectively). In the present study, 54% of the patients displayed genotypes encoding low MBL plasma levels (A0), of whom 54.09% had periodontal disease and 53.84% were healthy controls. Neither the present study nor that of Louropoulou et al. (28) and Araújo et al. (29) was able to detect any statistically significant differences in the genotype frequencies between periodontitis patients and healthy controls. The results of this study may have had interference of some limitations such as: sample size and no characterization of group ethnic.
In a previous study, Maffei et al. (26) analyzed MBL plasma levels in relation to periodontitis and demonstrated that MBL levels were not high in periodontitis and that MBL deficiency was not related to susceptibility to periodontitis. Despite those results are in agreement with the data recorded by this study and do not offer a basis for implicating MBL deficiency in the pathogenesis of periodontitis, further studies with different ethnic groups will be needed before more substantiated conclusions can be drawn.
Conclusion
This study indicates that the polymorphisms in exon-1 of the MBL2 gene are not related to periodontal disease in a type 2 diabetic population.
